Teva Pharmaceuticals USA recalls Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals
Teva recalls 27mg Methylphenidate extended-release tablets due to possible missing desiccant, which may cause moisture damage. This is a controlled substance prescription-only product.
Lower-risk recall
CGMP deviations: Product bottle may be absent of desiccant.
Contact the company & request your remedy
What happened, in plain English
Teva Pharmaceuticals is recalling 27mg Methylphenidate hydrochloride Extended-Release tablets (100-count) because the product bottles might not contain the desiccant. This could lead to moisture damage affecting the medication's stability. Read more at govinfonow.com/recall/37397-teva-methylphenidate-extended-release-recall-missing-desiccant-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/37397-teva-methylphenidate-extended-release-recall-missing-desiccant-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0837-2020
Cite this page
“Teva Methylphenidate Extended-Release Recall: Missing Desiccant Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37397-teva-methylphenidate-extended-release-recall-missing-desiccant-risk. Based on FDA recall #D-0837-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0837-2020%22&limit=1).
Why it’s dangerous
The product bottles may be missing the desiccant, which helps keep the medication dry. Without it, moisture could damage the tablets, potentially affecting their effectiveness or safety.
Who’s affected
Prescription patients who have the 27mg Methylphenidate extended-release tablets (NDC 62037-734-01) from Teva Pharmaceuticals. Those with the product may be at risk if the desiccant is missing.
How to tell if you have this one
Check for the product name 'Methylphenidate hydrochloride Extended-Release ablets USP (CII)', 27 mg, 100-count bottle, prescription-only from Teva Pharmaceuticals. The lot number is 1332799A with an expiration date of November 2020.
- Brand
Teva Pharmaceuticals- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
USA Nationwide- NDC
62037-725-01, 62037-734-01, 62037-726-01, 62037-727-01
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0836-2020 | Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-725-01; Lot #: 1332796 A, Exp 11/2020 | — |
| D-0837-2020 | Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-734-01; Lot # 1332799A, Exp 11/2020 | 17,436 bottles |
What to do — step by step
Check Product Details
Verify the product name, strength, and lot number to confirm if it matches the recalled items.
Questions people ask
Is this product safe to use?
The recall is due to possible missing desiccant, which could affect the medication's stability. The product may still be safe if the desiccant is present, but it's recommended to check with the manufacturer.
What should I do if I have this product?
The recall does not specify a remedy, so check with Teva Pharmaceuticals for guidance on whether to use or return the product.
How can I confirm if my product is recalled?
Look for the product name 'Methylphenidate hydrochloride Extended-Release ablets USP (CII)', 27 mg, 100-count bottle, with lot number 1332799A and expiration date November 2020.
Contact Teva Pharmaceuticals
We’ve drafted a message you can send Teva Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0837-2020 — Teva Pharmaceuticals Teva Pharmaceuticals Hello, I own a Teva Pharmaceuticals that is covered by recall D-0837-2020 from Teva Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0837-2020 (January 27, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0837-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.